TCR2 Therapeutics
TCR2 Therapeutics Inc. has combined with Adaptimmune Therapeutics
Financial Advisor
BridgetoLife
TransMedics
Bridge to Life, Ltd.
Bridge to Life, Ltd. has sold EVOSS and LifeCradle perfusion technology assets to TransMedics
Financial Advisor
$60.0 Million
Inozyme
Inozyme Pharma, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$149.9 Million
Procept
Procept Biorobotics Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$25.0 Million
Ridgeview_Medical
Ridgeview Medical Center
Secured Senior Notes
Ridgeview Medical Center, MN
2023
Sole Placement Agent
Check this box to show "details" button on tombstone
Off
$22.0 Million
Ridgeview_Medical
Ridgeview Medical Center
Health Facilities Revenue Note
Ridgeview Medical Center, MN
2023A
Sole Placement Agent
Check this box to show "details" button on tombstone
Off
Bluesight
Medacist
Thoma
Bluesight, Inc.
Financial Advisor
Medaxion
Medaxion, Inc.
Medaxion has received an equity investment from McCarthy Capital
Financial Advisor
$75.0 Million
BlackDiamond
Black Diamond Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
NextPhase
Kidd
Arterex
InvestIndustrial
NextPhase Medical Devices
NextPhase Medical Devices, a portfolio company of Kidd & Company, LLC, has sold to Arterex, a portfolio company of Investindustrial
Financial Advisor
Subscribe to Healthcare

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.